# CHI-902 for Treatment of Social Anxiety Disorder

> **NCT04086342** · PHASE2 · WITHDRAWN · sponsor: **Canopy Growth Corporation**

## Conditions studied

- Social Anxiety Disorder

## Interventions

- **DRUG:** CHI-902
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04086342
- **Lead sponsor:** Canopy Growth Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01-24
- **Primary completion:** 2021-01-26
- **Final completion:** 2021-01-26
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Changes in pipeline
- **Last updated:** 2020-06-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04086342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04086342, "CHI-902 for Treatment of Social Anxiety Disorder". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04086342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*